Distribution and activity of doxorubicin combined with SDZ PSC 833 in mice with P388 and P388/DOX leukaemia.

SDZ PSC 833 (PSC 833) is a non-immunosuppressive analogue of cyclosporin A and is a potent modifier of P-glycoprotein (P-gp)-mediated multidrug resistance. The present study was undertaken to evaluate whether doxorubicin (DOX) pharmacokinetic and anti-tumour activity on P388- and P388/DOX-resistant...

Descripción completa

Detalles Bibliográficos
Autores principales: Colombo, T., Gonzalez Paz, O., D'Incalci, M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074272/
https://www.ncbi.nlm.nih.gov/pubmed/8611397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074272/
https://www.ncbi.nlm.nih.gov/pubmed/8611397

Ejemplares similares